{"id":1219,"date":"2020-04-01T17:44:42","date_gmt":"2020-04-01T20:44:42","guid":{"rendered":"https:\/\/www.diabetes.org.br\/?p=1219"},"modified":"2020-09-11T09:41:26","modified_gmt":"2020-09-11T12:41:26","slug":"guia-de-bolso-abordagem-da-hiperglicemia-hospitalar-em-pacientes-criticos-e-nao-criticos-com-ou-sem-diabetes-previo-durante-a-pandemia-da-covid-19","status":"publish","type":"post","link":"https:\/\/diabetes.org.br\/covid-19\/guia-de-bolso-abordagem-da-hiperglicemia-hospitalar-em-pacientes-criticos-e-nao-criticos-com-ou-sem-diabetes-previo-durante-a-pandemia-da-covid-19\/","title":{"rendered":"Guia de Bolso &#8211; &#8220;Abordagem da hiperglicemia hospitalar em pacientes cr\u00edticos e n\u00e3o cr\u00edticos (com ou sem diabetes pr\u00e9vio) durante a pandemia da COVID-19&#8221;"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"1219\" class=\"elementor elementor-1219\">\n\t\t\t\t\t\t<div class=\"elementor-inner\">\n\t\t\t\t<div class=\"elementor-section-wrap\">\n\t\t\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-5380c70a elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"5380c70a\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t\t\t<div class=\"elementor-row\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-2b167fac\" data-id=\"2b167fac\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-column-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6d9dc776 elementor-widget elementor-widget-text-editor\" data-id=\"6d9dc776\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-text-editor elementor-clearfix\">\n\t\t\t\t<!-- wp:group -->\n<div class=\"wp-block-group\">\n<div class=\"wp-block-group__inner-container\"><!-- wp:image {\"align\":\"center\",\"id\":2355,\"sizeSlug\":\"large\"} -->\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img decoding=\"async\" loading=\"lazy\" width=\"361\" height=\"244\" class=\"wp-image-2355\" src=\"https:\/\/www.diabetes.org.br\/covid-19\/wp-content\/uploads\/2020\/06\/mockup_guia_de_bolso.png\" alt=\"\" srcset=\"https:\/\/diabetes.org.br\/covid-19\/wp-content\/uploads\/2020\/06\/mockup_guia_de_bolso.png 361w, https:\/\/diabetes.org.br\/covid-19\/wp-content\/uploads\/2020\/06\/mockup_guia_de_bolso-300x203.png 300w\" sizes=\"(max-width: 361px) 100vw, 361px\" \/><\/figure>\n<\/div>\n<!-- \/wp:image --><!-- wp:button {\"backgroundColor\":\"vivid-red\",\"align\":\"center\"} -->\n<div class=\"wp-block-button aligncenter\"><a class=\"wp-block-button__link has-background has-vivid-red-background-color\" href=\"https:\/\/www.diabetes.org.br\/covid-19\/wp-content\/uploads\/2020\/09\/Emkt_SBD_Diabetes_na_Era_COVID-19_Horizontal_02-1.png\" target=\"_blank\" rel=\"noreferrer noopener\">DOWNLOAD DO GUIA<\/a><\/div>\n<!-- \/wp:button --><\/div>\n<\/div>\n<!-- \/wp:group --><!-- wp:paragraph -->\n<p>\u00a0<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph {\"fontSize\":\"medium\"} -->\n<p class=\"has-medium-font-size\"><strong>Guia de Bolso<\/strong><\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p>&#8220;Abordagem da hiperglicemia hospitalar em pacientes cr\u00edticos e n\u00e3o cr\u00edticos (com ou sem diabetes pr\u00e9vio) durante a pandemia da COVID-19&#8243;Admiss\u00e3o<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p><strong>1.<\/strong> Medir a glicemia capilar na admiss\u00e3o de todos os internados, independente do diagn\u00f3stico de DM pois a hiperglicemia aumenta a mortalidade hospitalar e o tratamento pode influenciar o progn\u00f3stico<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p><strong>2. <\/strong>Registrar o diagn\u00f3stico de DM no prontu\u00e1rio para facilitar a identifica\u00e7\u00e3o<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p><strong>3.<\/strong> Avaliar a prescri\u00e7\u00e3o: manter o uso de insulina e suspender antidiab\u00e9ticos orais<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p><strong>4.<\/strong> Orientar o risco e observar sintomas de hipoglicemia no uso de sulfonilureia ou insulina, principalmente em idosos e nas altera\u00e7\u00f5es de fun\u00e7\u00e3o renal<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p><strong>5. <\/strong>Conv\u00e9m dosar a A1c (se n\u00e3o houver A1c dispon\u00edvel nos \u00faltimos 3 meses)<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p><strong>6. <\/strong>Manter a dieta ou aporte de glicose, mesmo se houver hiperglicemia<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph {\"customTextColor\":\"#a50000\"} -->\n<p class=\"has-text-color\" style=\"color: #a50000;\"><strong>Hipoglicemia (&lt;70 mg\/dL)<\/strong><\/p>\n<!-- \/wp:paragraph --><!-- wp:image {\"align\":\"left\",\"id\":2367,\"width\":406,\"height\":270,\"sizeSlug\":\"large\"} -->\n<div class=\"wp-block-image\">\n<figure class=\"alignleft size-large is-resized\"><img decoding=\"async\" loading=\"lazy\" class=\"wp-image-2367\" src=\"https:\/\/www.diabetes.org.br\/covid-19\/wp-content\/uploads\/2020\/06\/imagem_glicemia.png\" alt=\"\" width=\"406\" height=\"270\" srcset=\"https:\/\/diabetes.org.br\/covid-19\/wp-content\/uploads\/2020\/06\/imagem_glicemia.png 396w, https:\/\/diabetes.org.br\/covid-19\/wp-content\/uploads\/2020\/06\/imagem_glicemia-300x200.png 300w\" sizes=\"(max-width: 406px) 100vw, 406px\" \/><\/figure>\n<\/div>\n<!-- \/wp:image --><!-- wp:paragraph -->\n<p>Oriente o paciente, acompanhante sobre os sinais e sintomas de hipoglicemia. Se houver sudorese, n\u00e1usea, palidez, taquicardia, mal estar, rebaixamento de consci\u00eancia, avalie a glicemia capilar.<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p>Mantenha aporte m\u00ednimo de carboidrato VO (4g\/h) ou EV (2g\/h). Rever a insulina se jejum ou m\u00e1 aceita\u00e7\u00e3o.<\/p>\n<!-- \/wp:paragraph --><!-- wp:heading {\"level\":4} -->\n<h4><strong>Corre\u00e7\u00e3o da hipoglicemia:<\/strong><\/h4>\n<!-- \/wp:heading --><!-- wp:paragraph -->\n<p>dieta VO ou enteral: 15g glicose VO (A\u00e7\u00facar 1 colher de sopa dilu\u00eddo em \u00e1gua)<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p>Inconscientes: glicose 50% (40mL EV) + acionar avalia\u00e7\u00e3o m\u00e9dica<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p>Reavaliar a glicemia em 15 min., avaliar causas (m\u00e1 aceita\u00e7\u00e3o, interrup\u00e7\u00e3o de carboidrato, insufici\u00eancia renal\/hep\u00e1tica)<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph {\"customTextColor\":\"#a50000\"} -->\n<p class=\"has-text-color\" style=\"color: #a50000;\"><strong>Hiperglicemia (&gt;180mg\/dL)<\/strong><\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p>Se houver glicemia &gt; 180 mg\/dL, confirmar com mais uma dosagem. Se confirmada avaliar a necessidade de prescri\u00e7\u00e3o de insulina basal.<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p><strong>Uma alternativa \u00e9 o esquema basal-bolus:<\/strong><\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p><strong>1<\/strong>.Insulina basal (0,2UI\/kg\/dia) insulina NPH (prefer\u00edvel fracionar em 2 a 3 doses) ou glargina (uma vez ao dia)<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p><strong>2.<\/strong>Insulina regular ou an\u00e1logo (lispro, aspart ou glulisina) (0,2UI\/Ikg fracionadas antes do caf\u00e9, almo\u00e7o e jantar associada a dose de corre\u00e7\u00e3o<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p><strong>3.<\/strong> Dose de corre\u00e7\u00e3o<\/p>\n<!-- \/wp:paragraph --><!-- wp:image {\"className\":\"imagens\"} -->\n<figure class=\"wp-block-image imagens\"><img decoding=\"async\" src=\"https:\/\/www.diabetes.org.br\/covid-19\/publico\/images\/Guia-imagem1.png\" alt=\"\" \/><\/figure>\n<!-- \/wp:image --><!-- wp:paragraph -->\n<p><strong>4.<\/strong> Reavaliar as doses a cada 24 a 48 h<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p><strong>5.<\/strong> Prover educa\u00e7\u00e3o do paciente e familiar<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p><strong>Pacientes graves (UTI)<\/strong><\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p><strong>1.<\/strong> Avaliar cetoacidose (ceton\u00faria) ou estado hiperosmolar (glicemia &gt; 600) pois tem protocolos espec\u00edficos e diferentes<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p><strong>2.<\/strong> Se houver 2 epis\u00f3dios de hiperglicemia (&gt;180 mg\/dL), iniciar 0,1UI\/kg\/h de insulina R EV cont\u00ednua (diluir 100UI em 100ml de SF0,9% e desprezar 20 mL) devido a meia-vida curta e a a\u00e7\u00e3o r\u00e1pida<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p><strong>3.<\/strong> controlar a glicemia a cada hora e ajustar a dose com algoritmos validados, com a meta de 140-180 mg\/dL.<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p>Exemplo Joint British Diabetes Society<\/p>\n<!-- \/wp:paragraph --><!-- wp:image {\"className\":\"imagens\"} -->\n<figure class=\"wp-block-image imagens\"><img decoding=\"async\" src=\"https:\/\/www.diabetes.org.br\/covid-19\/publico\/images\/Guia-imagem2.png\" alt=\"\" \/><\/figure>\n<!-- \/wp:image --><!-- wp:paragraph -->\n<p>ou www.insulinapp-uti.com.br<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p><strong>4.<\/strong> Monitorar o equil\u00edbrio hidroeletrol\u00edtico<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p><strong>5.<\/strong> Administrar insulina NPH ou an\u00e1logo SC 3 h antes de suspender a insulina EV<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p><strong>Respons\u00e1veis pela elabora\u00e7\u00e3o:<\/strong><\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph {\"customFontSize\":14} -->\n<p style=\"font-size: 14px;\">Denise Momesso, Marcos Tadashi, Marcio Krakauer, Paulo Miranda, Rubens Sarga\u00e7o, Rog\u00e9rio Silicani, Emerson Marino, Priscilla Cukier, Joaquim Cust\u00f3dio, Alexandre de Souza, Hermelinda Pedrosa, Rodrigo Lamounier, Roberto Raduan, Solange Travassos, Mariani Batista, Lenita Zajdenverg, Silmara Leite, Melanie Rodacki Alina Feitosa<\/p>\n<!-- \/wp:paragraph --><!-- wp:button {\"backgroundColor\":\"vivid-red\"} -->\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-background has-vivid-red-background-color\" href=\"https:\/\/www.diabetes.org.br\/covid-19\/wp-content\/uploads\/2020\/09\/Emkt_SBD_Diabetes_na_Era_COVID-19_Horizontal_02-1.png\" target=\"_blank\" rel=\"noreferrer noopener\">BAIXE AGORA<\/a><\/div>\n<!-- \/wp:button -->\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>\u00a0 Guia de Bolso &#8220;Abordagem da hiperglicemia hospitalar em pacientes cr\u00edticos e n\u00e3o cr\u00edticos (com ou sem diabetes pr\u00e9vio) durante a pandemia da COVID-19&#8243;Admiss\u00e3o 1. Medir a glicemia capilar na admiss\u00e3o de todos os internados, independente do diagn\u00f3stico de DM pois a hiperglicemia aumenta a mortalidade hospitalar e o tratamento pode influenciar o progn\u00f3stico 2. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1289,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[17],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.2.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Guia de Bolso - &quot;Abordagem da hiperglicemia hospitalar em pacientes cr\u00edticos e n\u00e3o cr\u00edticos (com ou sem diabetes pr\u00e9vio) durante a pandemia da COVID-19&quot; - Diabetes na era Covid-19<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/diabetes.org.br\/covid-19\/guia-de-bolso-abordagem-da-hiperglicemia-hospitalar-em-pacientes-criticos-e-nao-criticos-com-ou-sem-diabetes-previo-durante-a-pandemia-da-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Guia de Bolso - &quot;Abordagem da hiperglicemia hospitalar em pacientes cr\u00edticos e n\u00e3o cr\u00edticos (com ou sem diabetes pr\u00e9vio) durante a pandemia da COVID-19&quot; - Diabetes na era Covid-19\" \/>\n<meta property=\"og:description\" content=\"\u00a0 Guia de Bolso &#8220;Abordagem da hiperglicemia hospitalar em pacientes cr\u00edticos e n\u00e3o cr\u00edticos (com ou sem diabetes pr\u00e9vio) durante a pandemia da COVID-19&#8243;Admiss\u00e3o 1. Medir a glicemia capilar na admiss\u00e3o de todos os internados, independente do diagn\u00f3stico de DM pois a hiperglicemia aumenta a mortalidade hospitalar e o tratamento pode influenciar o progn\u00f3stico 2. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/diabetes.org.br\/covid-19\/guia-de-bolso-abordagem-da-hiperglicemia-hospitalar-em-pacientes-criticos-e-nao-criticos-com-ou-sem-diabetes-previo-durante-a-pandemia-da-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"Diabetes na era Covid-19\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-01T20:44:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-09-11T12:41:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/diabetes.org.br\/covid-19\/wp-content\/uploads\/2020\/04\/837-1-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"agurgel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"agurgel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/diabetes.org.br\/covid-19\/guia-de-bolso-abordagem-da-hiperglicemia-hospitalar-em-pacientes-criticos-e-nao-criticos-com-ou-sem-diabetes-previo-durante-a-pandemia-da-covid-19\/\",\"url\":\"https:\/\/diabetes.org.br\/covid-19\/guia-de-bolso-abordagem-da-hiperglicemia-hospitalar-em-pacientes-criticos-e-nao-criticos-com-ou-sem-diabetes-previo-durante-a-pandemia-da-covid-19\/\",\"name\":\"Guia de Bolso - \\\"Abordagem da hiperglicemia hospitalar em pacientes cr\u00edticos e n\u00e3o cr\u00edticos (com ou sem diabetes pr\u00e9vio) durante a pandemia da COVID-19\\\" - Diabetes na era Covid-19\",\"isPartOf\":{\"@id\":\"https:\/\/diabetes.org.br\/covid-19\/#website\"},\"datePublished\":\"2020-04-01T20:44:42+00:00\",\"dateModified\":\"2020-09-11T12:41:26+00:00\",\"author\":{\"@id\":\"https:\/\/diabetes.org.br\/covid-19\/#\/schema\/person\/ed34b0861865c7e305ab59e64fd535ec\"},\"breadcrumb\":{\"@id\":\"https:\/\/diabetes.org.br\/covid-19\/guia-de-bolso-abordagem-da-hiperglicemia-hospitalar-em-pacientes-criticos-e-nao-criticos-com-ou-sem-diabetes-previo-durante-a-pandemia-da-covid-19\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/diabetes.org.br\/covid-19\/guia-de-bolso-abordagem-da-hiperglicemia-hospitalar-em-pacientes-criticos-e-nao-criticos-com-ou-sem-diabetes-previo-durante-a-pandemia-da-covid-19\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/diabetes.org.br\/covid-19\/guia-de-bolso-abordagem-da-hiperglicemia-hospitalar-em-pacientes-criticos-e-nao-criticos-com-ou-sem-diabetes-previo-durante-a-pandemia-da-covid-19\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/diabetes.org.br\/covid-19\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Guia de Bolso &#8211; &#8220;Abordagem da hiperglicemia hospitalar em pacientes cr\u00edticos e n\u00e3o cr\u00edticos (com ou sem diabetes pr\u00e9vio) durante a pandemia da COVID-19&#8221;\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/diabetes.org.br\/covid-19\/#website\",\"url\":\"https:\/\/diabetes.org.br\/covid-19\/\",\"name\":\"Diabetes na era Covid-19\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/diabetes.org.br\/covid-19\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/diabetes.org.br\/covid-19\/#\/schema\/person\/ed34b0861865c7e305ab59e64fd535ec\",\"name\":\"agurgel\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/diabetes.org.br\/covid-19\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d5f7db0120b0aea0932ecc0b4ed8398c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d5f7db0120b0aea0932ecc0b4ed8398c?s=96&d=mm&r=g\",\"caption\":\"agurgel\"},\"url\":\"https:\/\/diabetes.org.br\/covid-19\/author\/agurgel\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Guia de Bolso - \"Abordagem da hiperglicemia hospitalar em pacientes cr\u00edticos e n\u00e3o cr\u00edticos (com ou sem diabetes pr\u00e9vio) durante a pandemia da COVID-19\" - Diabetes na era Covid-19","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/diabetes.org.br\/covid-19\/guia-de-bolso-abordagem-da-hiperglicemia-hospitalar-em-pacientes-criticos-e-nao-criticos-com-ou-sem-diabetes-previo-durante-a-pandemia-da-covid-19\/","og_locale":"pt_BR","og_type":"article","og_title":"Guia de Bolso - \"Abordagem da hiperglicemia hospitalar em pacientes cr\u00edticos e n\u00e3o cr\u00edticos (com ou sem diabetes pr\u00e9vio) durante a pandemia da COVID-19\" - Diabetes na era Covid-19","og_description":"\u00a0 Guia de Bolso &#8220;Abordagem da hiperglicemia hospitalar em pacientes cr\u00edticos e n\u00e3o cr\u00edticos (com ou sem diabetes pr\u00e9vio) durante a pandemia da COVID-19&#8243;Admiss\u00e3o 1. Medir a glicemia capilar na admiss\u00e3o de todos os internados, independente do diagn\u00f3stico de DM pois a hiperglicemia aumenta a mortalidade hospitalar e o tratamento pode influenciar o progn\u00f3stico 2. [&hellip;]","og_url":"https:\/\/diabetes.org.br\/covid-19\/guia-de-bolso-abordagem-da-hiperglicemia-hospitalar-em-pacientes-criticos-e-nao-criticos-com-ou-sem-diabetes-previo-durante-a-pandemia-da-covid-19\/","og_site_name":"Diabetes na era Covid-19","article_published_time":"2020-04-01T20:44:42+00:00","article_modified_time":"2020-09-11T12:41:26+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/diabetes.org.br\/covid-19\/wp-content\/uploads\/2020\/04\/837-1-scaled.jpg","type":"image\/jpeg"}],"author":"agurgel","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"agurgel","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/diabetes.org.br\/covid-19\/guia-de-bolso-abordagem-da-hiperglicemia-hospitalar-em-pacientes-criticos-e-nao-criticos-com-ou-sem-diabetes-previo-durante-a-pandemia-da-covid-19\/","url":"https:\/\/diabetes.org.br\/covid-19\/guia-de-bolso-abordagem-da-hiperglicemia-hospitalar-em-pacientes-criticos-e-nao-criticos-com-ou-sem-diabetes-previo-durante-a-pandemia-da-covid-19\/","name":"Guia de Bolso - \"Abordagem da hiperglicemia hospitalar em pacientes cr\u00edticos e n\u00e3o cr\u00edticos (com ou sem diabetes pr\u00e9vio) durante a pandemia da COVID-19\" - Diabetes na era Covid-19","isPartOf":{"@id":"https:\/\/diabetes.org.br\/covid-19\/#website"},"datePublished":"2020-04-01T20:44:42+00:00","dateModified":"2020-09-11T12:41:26+00:00","author":{"@id":"https:\/\/diabetes.org.br\/covid-19\/#\/schema\/person\/ed34b0861865c7e305ab59e64fd535ec"},"breadcrumb":{"@id":"https:\/\/diabetes.org.br\/covid-19\/guia-de-bolso-abordagem-da-hiperglicemia-hospitalar-em-pacientes-criticos-e-nao-criticos-com-ou-sem-diabetes-previo-durante-a-pandemia-da-covid-19\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/diabetes.org.br\/covid-19\/guia-de-bolso-abordagem-da-hiperglicemia-hospitalar-em-pacientes-criticos-e-nao-criticos-com-ou-sem-diabetes-previo-durante-a-pandemia-da-covid-19\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/diabetes.org.br\/covid-19\/guia-de-bolso-abordagem-da-hiperglicemia-hospitalar-em-pacientes-criticos-e-nao-criticos-com-ou-sem-diabetes-previo-durante-a-pandemia-da-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/diabetes.org.br\/covid-19\/"},{"@type":"ListItem","position":2,"name":"Guia de Bolso &#8211; &#8220;Abordagem da hiperglicemia hospitalar em pacientes cr\u00edticos e n\u00e3o cr\u00edticos (com ou sem diabetes pr\u00e9vio) durante a pandemia da COVID-19&#8221;"}]},{"@type":"WebSite","@id":"https:\/\/diabetes.org.br\/covid-19\/#website","url":"https:\/\/diabetes.org.br\/covid-19\/","name":"Diabetes na era Covid-19","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/diabetes.org.br\/covid-19\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/diabetes.org.br\/covid-19\/#\/schema\/person\/ed34b0861865c7e305ab59e64fd535ec","name":"agurgel","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/diabetes.org.br\/covid-19\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d5f7db0120b0aea0932ecc0b4ed8398c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d5f7db0120b0aea0932ecc0b4ed8398c?s=96&d=mm&r=g","caption":"agurgel"},"url":"https:\/\/diabetes.org.br\/covid-19\/author\/agurgel\/"}]}},"_links":{"self":[{"href":"https:\/\/diabetes.org.br\/covid-19\/wp-json\/wp\/v2\/posts\/1219"}],"collection":[{"href":"https:\/\/diabetes.org.br\/covid-19\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/diabetes.org.br\/covid-19\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/diabetes.org.br\/covid-19\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/diabetes.org.br\/covid-19\/wp-json\/wp\/v2\/comments?post=1219"}],"version-history":[{"count":29,"href":"https:\/\/diabetes.org.br\/covid-19\/wp-json\/wp\/v2\/posts\/1219\/revisions"}],"predecessor-version":[{"id":3006,"href":"https:\/\/diabetes.org.br\/covid-19\/wp-json\/wp\/v2\/posts\/1219\/revisions\/3006"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/diabetes.org.br\/covid-19\/wp-json\/wp\/v2\/media\/1289"}],"wp:attachment":[{"href":"https:\/\/diabetes.org.br\/covid-19\/wp-json\/wp\/v2\/media?parent=1219"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/diabetes.org.br\/covid-19\/wp-json\/wp\/v2\/categories?post=1219"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/diabetes.org.br\/covid-19\/wp-json\/wp\/v2\/tags?post=1219"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}